LLY
Eli Lilly and Company
LLY has the edge over OGI overall, supported by stronger fundamentals and lower modeled downside.
OGI
Organigram Global Inc.
OGI's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
OGI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Healthy |
OGI's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is weak.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
OGI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.9x | $0.83 | — |
| Cheap | 8x | $3.58 | +331% |
| Fair | 14x | $6.30 | +659% |
| Expensive | 28x | $12.62 | +1421% |
Historical ranges are pointers, not guarantees.
OGI has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
OGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect OGI to return to profit, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over OGI on earnings, with more consistent year-over-year improvement.
OGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.45 | +$0.45 |
| Q1 2026 | -$0.13 | -360% |
| Q4 2025 | $0.10 | +$0.49 |
| Q3 2025 | -$0.15 | +$0.23 |
| Q2 2025 | -$0.00 | +$0.61 |
| Q2 2024 | -$0.61 | +$1.34 |
| Q2 2023 | -$1.95 | -$1.63 |
| Q1 2023 | -$0.10 | +$0.25 |
OGI has returned to profit: it earned $0.45 per share over the past year, after losing money the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over OGI on profitability, with a higher operating margin.
OGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $74.4M | +49% |
| Q1 2026 | $42M | -8.9% |
| Q4 2025 | $44.6M | +49% |
| Q3 2025 | $56.3M | +79% |
| Q2 2025 | $49.8M | +72% |
| Q1 2025 | $46.1M | +74% |
| Q4 2024 | $30M | +17% |
| Q3 2024 | $31.4M | -2.9% |
OGI's revenue is growing: $74M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5% | +8 points |
| Q1 2026 | -16% | -4.8 points |
| Q4 2025 | -5.4% | +11 points |
| Q3 2025 | 1.5% | +0.9 points |
| Q2 2025 | -3% | +9.3 points |
| Q1 2025 | -12% | +29 points |
| Q4 2024 | -16% | +28 points |
| Q3 2024 | 0.6% | +86 points |
OGI's operating margin was 5% last quarter, up 8 points from the same quarter a year ago, near the top of its range since 2019.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over OGI on cash generation, producing positive trailing cash flow while its opponent burns cash.
OGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.7M | -177% |
| Q1 2026 | -$4.9M | +$11.3M |
| Q4 2025 | -$12.7M | -$8.6M |
| Q3 2025 | -$483.7K | -110% |
| Q2 2025 | $3.5M | +$6.9M |
| Q1 2025 | -$16.3M | -$9.4M |
| Q4 2024 | -$4.1M | -194% |
| Q3 2024 | $4.9M | +$21.3M |
OGI has burned cash in almost every quarter: −$21M over the past year, against −$12M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over OGI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
OGI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +5M shares |
| 1 year | +2% | +2.6M shares |
| 3 years | +71% | +56.6M shares |
| 5 years | +142% | +80.2M shares |
| Available history | +262% | +98.8M shares |
OGI has 137M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OGI hasn't bought back shares in the past year.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
OGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -8.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -7.3x | Net Cash |
| Q2 2025 | -7.0x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q1 2023 | -4.0x | Net Cash |
| Q4 2022 | -3.9x | Net Cash |
OGI has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
OGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.6 | Neutral |
| Stochastic | 4.9 | Oversold |
OGI's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
OGI PE vs Healthcare Sector
| Metric | OGI | Sector median | Relative |
|---|---|---|---|
| PE | 1.9x | 26x | 93% below |
| PE % | 0 | 29 | 29 pts below |
OGI has the edge over LLY on valuation relative to its sector.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over OGI on trend strength, trading above more of its moving averages.
OGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.94 | 12% below |
| 20 week MA | $1.01 | 18% below |
| 50 week MA | $1.26 | 34% below |
| 100 week MA | $1.35 | 39% below |
| 200 week MA | $1.59 | 48% below |
OGI is in a downtrend: it's below all five of its weekly moving averages, and 48% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over OGI on returns for 2026, with the stronger performance.
OGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.40 | $5.68 | -40% |
| 2021 | $5.68 | $8.00 | +41% |
| 2022 | $8.00 | $3.12 | -61% |
| 2023 | $3.12 | $1.31 | -58% |
| 2024 | $1.31 | $1.62 | +24% |
| 2025 | $1.62 | $1.79 | +10% |
| 2026 YTD | $1.79 | $0.83 | -54% |
OGI has finished lower in three of the last six years. It's down 54% so far in 2026.